Single-cell resolution imaging of retinal ganglion cell apoptosis in vivo using a cell-penetrating caspase-activatable peptide probe.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 3931650)

Published in PLoS One on February 21, 2014

Authors

Xudong Qiu1, James R Johnson2, Bradley S Wilson3, Seth T Gammon4, David Piwnica-Worms5, Edward M Barnett3

Author Affiliations

1: Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, United States of America ; Molecular Imaging Center, Mallinckrodt Institute of Radiology, BRIGHT Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America ; Department of Cancer Systems Imaging, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America.
2: Molecular Imaging Center, Mallinckrodt Institute of Radiology, BRIGHT Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America.
3: Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, United States of America.
4: Department of Cancer Systems Imaging, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America.
5: Molecular Imaging Center, Mallinckrodt Institute of Radiology, BRIGHT Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America ; Department of Cancer Systems Imaging, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America.

Articles citing this

A semi-automated technique for labeling and counting of apoptosing retinal cells. BMC Bioinformatics (2014) 0.85

Glaucoma: the retina and beyond. Acta Neuropathol (2016) 0.84

Advances in retinal ganglion cell imaging. Eye (Lond) (2015) 0.80

Exciting directions in glaucoma. Can J Ophthalmol (2014) 0.78

Evaluating retinal ganglion cell loss and dysfunction. Exp Eye Res (2016) 0.75

Articles cited by this

NIH Image to ImageJ: 25 years of image analysis. Nat Methods (2012) 84.41

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods (1995) 16.00

Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol (1992) 11.24

Imaging in the era of molecular oncology. Nature (2008) 11.10

The major cell populations of the mouse retina. J Neurosci (1998) 7.18

Neuronal death in glaucoma. Prog Retin Eye Res (1999) 3.46

Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc Natl Acad Sci U S A (2010) 3.41

Apoptosis in the development and maintenance of the immune system. Nat Immunol (2003) 3.02

Spying on cancer: molecular imaging in vivo with genetically encoded reporters. Cancer Cell (2005) 2.74

Intracellular responses of the Müller (glial) cells of mudpuppy retina: their relation to b-wave of the electroretinogram. J Neurophysiol (1970) 2.45

Caspases and caspase inhibitors. Trends Biochem Sci (1997) 2.17

Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc Natl Acad Sci U S A (2004) 1.90

Apoptosis-regulating proteins as targets for drug discovery. Trends Mol Med (2001) 1.74

Rodent models for glaucoma retinopathy and optic neuropathy. J Glaucoma (2007) 1.70

Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma. Nat Rev Drug Discov (2012) 1.52

A systematic review of the adverse events of intravitreal anti-vascular endothelial growth factor injections. Retina (2011) 1.47

Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model. Proc Natl Acad Sci U S A (2009) 1.40

Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma. PLoS One (2012) 1.35

An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging. Bioconjug Chem (2009) 1.34

Biochemical and in vivo characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. Biochemistry (2007) 1.27

Potassium and the photoreceptor-dependent pigment epithelial hyperpolarization. J Gen Physiol (1977) 1.25

Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy. Neoplasia (2003) 1.18

Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application. J Nucl Med (2003) 1.14

Impaired hyaloidal circulation function and uncoordinated ocular growth patterns in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci (1998) 1.12

Synthesis and characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. J Med Chem (2005) 1.11

Characterization of novel histidine-tagged Tat-peptide complexes dual-labeled with (99m)Tc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopy. Bioconjug Chem (2002) 1.10

Selective cell uptake of modified Tat peptide-fluorophore conjugates in rat retina in ex vivo and in vivo models. Invest Ophthalmol Vis Sci (2006) 1.04

Permeation peptide conjugates for in vivo molecular imaging applications. Mol Imaging (2006) 1.03

Innovative strategies in in vivo apoptosis imaging. Curr Med Chem (2008) 0.98

In vivo monitoring of apoptosis. Prog Neuropsychopharmacol Biol Psychiatry (2003) 0.97

Imaging apoptosis in the eye. Eye (Lond) (2011) 0.96

Caspase-activated cell-penetrating peptides reveal temporal coupling between endosomal release and apoptosis in an RGC-5 cell model. Bioconjug Chem (2012) 0.94

The cell and molecular biology of glaucoma: axonopathy and the brain. Invest Ophthalmol Vis Sci (2012) 0.91